Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2004 | 09-2004 | 06-2004 | |
| Cash Flows From Operating Activities | |||
| Net Income | -4,620 | -1,850 | -1,220 |
| Depreciation Amortization | 1,010 | 160 | 140 |
| Other Working Capital | 40 | 150 | 120 |
| Other Operating Activity | 1,450 | 860 | 840 |
| Operating Cash Flow | $-2,120 | $-680 | $-120 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -170 | -10 | -4 |
| Other Investing Activity | -230 | -110 | -106 |
| Investing Cash Flow | $-400 | $-120 | $-110 |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 3,380 | 1,850 | 240 |
| Financing Cash Flow | $3,380 | $1,850 | $240 |
| End Cash Position | 850 | 1,040 | 6 |
| Net Cash Flow | $850 | $1,040 | $6 |
| Free Cash Flow | |||
| Operating Cash Flow | -2,120 | -680 | -120 |
| Free Cash Flow | -2,120 | -680 | -120 |